CTS Reports Strong Q2 Results with Revenue Growth and Record Margins
CTS Corporation (NYSE: CTS) reported strong financial results for its second quarter in 2026, driven by growth across diversified markets. The company achieved a revenue increase of 7% year-over-year to $144.8 million, with adjusted gross margin reaching a record high of 41.5%. Adjusted earnings per share (EPS) rose approximately 30% to $0.74. Medical and industrial segments were key contributors, with medical revenue surging by 45%, while aerospace and defense are expected to improve in the second half of the year. Transportation sales declined slightly but new awards totaled around $163 million, including a significant sensor contract worth approximately $100 million. CTS raised its full-year outlook for both revenue and adjusted diluted EPS. In his first earnings call as CEO, Pratik Trivedi emphasized that the company's Evolution 2030 strategy remains central to long-term value creation despite challenges in transportation markets, tariffs, and input costs.
Tickers: $CTS
Topics: adjusted_gross_margin diversified_markets financial_results revenue_growth